112 related articles for article (PubMed ID: 10419920)
41. kappa-Opioid receptor stimulation inhibits augmentation of Ca(2+) transient and hypertrophy induced by isoprenaline in neonatal rat ventricular myocytes - Role of CaMKIIdelta(B).
Wu G; Wang H; Yang J; Yang Y; Liu C; Jing L; Wong TM
Eur J Pharmacol; 2008 Oct; 595(1-3):52-7. PubMed ID: 18721804
[TBL] [Abstract][Full Text] [Related]
42. Effects of acute agonist treatment on subcellular distribution of kappa opioid receptor in rat spinal cord.
Wang Y; Xu W; Huang P; Chavkin C; Van Bockstaele EJ; Liu-Chen LY
J Neurosci Res; 2009 May; 87(7):1695-702. PubMed ID: 19130621
[TBL] [Abstract][Full Text] [Related]
43. Opioid receptor subtypes differentially modulate serotonin efflux in the rat central nervous system.
Tao R; Auerbach SB
J Pharmacol Exp Ther; 2002 Nov; 303(2):549-56. PubMed ID: 12388635
[TBL] [Abstract][Full Text] [Related]
44. Distinct antinociceptive actions mediated by different opioid receptors in the region of lamina I and laminae III-V of the dorsal horn of the rat.
Hope PJ; Fleetwood-Walker SM; Mitchell R
Br J Pharmacol; 1990 Oct; 101(2):477-83. PubMed ID: 2175238
[TBL] [Abstract][Full Text] [Related]
45. Kappa-opioid receptor-mediated antinociception in the rat. II. Supraspinal in addition to spinal sites of action.
Millan MJ; Członkowski A; Lipkowski A; Herz A
J Pharmacol Exp Ther; 1989 Oct; 251(1):342-50. PubMed ID: 2571723
[TBL] [Abstract][Full Text] [Related]
46. Chemical activation of cervical cell bodies: effects on responses to colorectal distension in lumbosacral spinal cord of rats.
Qin C; Chandler MJ; Miller KE; Foreman RD
J Neurophysiol; 1999 Dec; 82(6):3423-33. PubMed ID: 10601473
[TBL] [Abstract][Full Text] [Related]
47. Ca2+ channel inhibition by kappa opioid receptors expressed in Xenopus oocytes.
Kaneko S; Fukuda K; Yada N; Akaike A; Mori Y; Satoh M
Neuroreport; 1994 Dec; 5(18):2506-8. PubMed ID: 7535119
[TBL] [Abstract][Full Text] [Related]
48. Kappa opioid receptor agonists suppress absence seizures in WAG/Rij rats.
Przewłocka B; Lasoń W; Machelska H; van Luijtelaar G; Coenen A; Przewłocki R
Neurosci Lett; 1995 Feb; 186(2-3):131-4. PubMed ID: 7777181
[TBL] [Abstract][Full Text] [Related]
49. Effects of acute and chronic administration of dizocilpine on the pharmacological responses to U-50,488H and brain and spinal cord kappa-opioid receptors in the rat.
Bhargava HN; Matwyshyn GA; Gudehithlu KP
Pharmacology; 1995 Nov; 51(5):323-30. PubMed ID: 8584584
[TBL] [Abstract][Full Text] [Related]
50. The comparison of effects of processed Aconiti tuber, U50488H and MK-801 on the antinociceptive tolerance to morphine.
Shu H; Hayashida M; Huang W; An K; Chiba S; Hanaoka K; Arita H
J Ethnopharmacol; 2008 Apr; 117(1):158-65. PubMed ID: 18328652
[TBL] [Abstract][Full Text] [Related]
51. Mechanism of direct Cav2.2 channel block by the κ-opioid receptor agonist U50488H.
Berecki G; Motin L; Adams DJ
Neuropharmacology; 2016 Oct; 109():49-58. PubMed ID: 27245500
[TBL] [Abstract][Full Text] [Related]
52. Kappa-opioid receptor stimulation abolishes mu- but not delta-mediated inhibitory control of spinal Met-enkephalin release.
Collin E; Bourgoin S; Ferhat L; Hamon M; Cesselin F
Neurosci Lett; 1992 Jan; 134(2):238-42. PubMed ID: 1317026
[TBL] [Abstract][Full Text] [Related]
53. Ketamine, an N-methyl-D-aspartate receptor antagonist, inhibits the spinal neuronal responses to distension of the rat urinary bladder.
Castroman PJ; Ness TJ
Anesthesiology; 2002 Jun; 96(6):1410-9. PubMed ID: 12170054
[TBL] [Abstract][Full Text] [Related]
54. Opioid control of the release of calcitonin gene-related peptide-like material from the rat spinal cord in vivo.
Collin E; Frechilla D; Pohl M; Bourgoin S; Le Bars D; Hamon M; Cesselin F
Brain Res; 1993 Apr; 609(1-2):211-22. PubMed ID: 8389648
[TBL] [Abstract][Full Text] [Related]
55. Cholecystokinin octapeptide reverses the kappa-opioid-receptor-mediated depression of calcium current in rat dorsal root ganglion neurons.
Xu T; Liu NJ; Li CQ; Shangguan Y; Yu YX; Kang HG; Han JS
Brain Res; 1996 Aug; 730(1-2):207-11. PubMed ID: 8883905
[TBL] [Abstract][Full Text] [Related]
56. Effects of U-69,593, a kappa-opioid receptor agonist, on carrageenin-induced peripheral oedema and Fos expression in the rat spinal cord.
Catheline G; Le Guen S; Besson JM
Eur J Pharmacol; 1999 Apr; 370(3):287-96. PubMed ID: 10334505
[TBL] [Abstract][Full Text] [Related]
57. Activation of the kappa-opioid receptor in Caco-2 cells decreases interleukin-8 secretion.
Neudeck BL; Loeb J; Buck J
Eur J Pharmacol; 2003 Apr; 467(1-3):81-4. PubMed ID: 12706459
[TBL] [Abstract][Full Text] [Related]
58. Modulation of spinal visceral nociceptive transmission by NMDA receptor activation in the rat.
Kolhekar R; Gebhart GF
J Neurophysiol; 1996 Jun; 75(6):2344-53. PubMed ID: 8793747
[TBL] [Abstract][Full Text] [Related]
59. Involvement of mu-, delta- and kappa-opioid receptor subtypes in the discriminative-stimulus effects of delta-9-tetrahydrocannabinol (THC) in rats.
Solinas M; Goldberg SR
Psychopharmacology (Berl); 2005 Jun; 179(4):804-12. PubMed ID: 15619107
[TBL] [Abstract][Full Text] [Related]
60. The effects of sham and full spinalization on the systemic potency of mu- and kappa-opioids on spinal nociceptive reflexes in rats.
Herrero JF; Headley PM
Br J Pharmacol; 1991 Sep; 104(1):166-70. PubMed ID: 1664760
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
